SCHEMBL3867756

SCHEMBL3867756

C#C[SnH]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL863849 0.55
SCHEMBL2825402 0.55
SCHEMBL18583040 0.55
SCHEMBL345819 0.55
SCHEMBL23721699 0.50
SCHEMBL6408462 0.50
SCHEMBL3818637 0.50
SCHEMBL130101 0.50
SCHEMBL449011 0.50
SCHEMBL5133363 0.50

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116082390-A Preparation method of diethyl zinc catalyzed organosilane compound 北京理工大学 2023-05-09 CN claimed
EP-2057145-A1 SYNTHESIS OF (2S,5R)-5-ETHYNYL-1-{N-(4-METHYL-1-(4-CARBOXY-PYRIDIN-2-YL)PIPERIDIN-4-YL)GLYCYL}PYRROLIDINE-2-CARBONITRILE Abbott Laboratories (US) 2009-05-13 EP claimed
WO-2008011499-A1 SYNTHESIS OF (2S,5R)-5-ETHYNYL-1-{N-(4-METHYL-1-(4-CARBOXY-PYRIDIN-2-YL)PIPERIDIN-4-YL)GLYCYL}PYRROLIDINE-2-CARBONITRILE ABBOTT LABORATORIES (US) 2008-01-24 WO claimed
US-5059590-A Antitumor agents YAMASA SHOYU KABUSHIKI KAISHA (JP) 1991-10-22 US claimed
EP-0331080-A2 Imidazole derivatives, process for production thereof, and use thereof Yamasa Shoyu Kabushiki Kaisha (JP) 1989-09-06 EP claimed
CN-116082390-B Preparation method of diethyl zinc catalyzed organosilane compound 北京理工大学 2025-08-08 CN disclosed
CN-114269756-B 4-Oxo-3, 4-dihydropyrido [3,4-D ] pyrimidine compounds that inhibit EIF4E 效应疗法股份有限公司 2024-05-14 CN disclosed
CN-113135929-B Furopyridone amide compound, preparation method and application thereof 江西济民可信集团有限公司 2024-04-19 CN disclosed
CN-112778277-B Cyclic ketone pyridone biaryl compound, preparation method and application thereof 江西济民可信集团有限公司 2024-04-02 CN disclosed
CN-115485281-B FGFR and mutation inhibitor thereof, and preparation method and application thereof 上海和誉生物医药科技有限公司 2023-11-21 CN disclosed
CN-116134035-A 3- (1H-imidazol-2-yl) -2,3,8 a-tetrahydroindol-5 (1H) -one derivatives useful as factor XIA inhibitors 詹森药业有限公司 2023-05-16 CN disclosed
CN-116096720-A Dihydropyrrolo [2,3-d ] pyridazin-7-one derivatives, preparation method and application thereof 上海和誉生物医药科技有限公司 2023-05-09 CN disclosed
US-6288228-B1 DIAMINOTRIAZINE DERIVATIVES ABBOTT LABORATORIES 2001-09-11 US disclosed
US-6211412-B1 REACTING BETA-KETO ESTER WITH HYDROGENATING AGENT IN PRESENCE OF ASYMMETRIC ORGANOMETALLIC MOLECULAR CATALYST COMPRISING METAL ATOM HAVING ONE OR MORE CHIRAL LIGANDS COUPLED THERETO, CONVERTING HYDROXYESTER FORMED TO EPOTHILONE PRECURSOR THE UNIVERSITY OF KANSAS 2001-04-03 US disclosed
US-6150362-A ADMINISTERING 1,3,5-SUBSTITUTED TRIAZINE COMPOUNDS TO THE PATIENT SUFFERING FROM ANGIOGENIC DISEASES ABBVIE INC. 2000-11-21 US disclosed
EP-1037886-A1 TRIAZINE ANGIOGENESIS INHIBITORS Abbott Laboratories (US) 2000-09-27 EP disclosed
WO-1999031088-A1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 1999-06-24 WO disclosed
US-5126361-A Antitumor agentss YAMASA SHOYU KABUSHIKI KAISHA (JP) 1992-06-30 US disclosed
US-5059590-A Antitumor agents YAMASA SHOYU KABUSHIKI KAISHA (JP) 1991-10-22 US disclosed
EP-0331080-A2 Imidazole derivatives, process for production thereof, and use thereof Yamasa Shoyu Kabushiki Kaisha (JP) 1989-09-06 EP disclosed